×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 2: Patient-Focused Label for the Future: Hot Air or Real Opportunities?
Session Chair(s)
Aimad Torqui
Division Head Medicines Evaluation Board
Medicines Evaluation Board, Netherlands
Session 2: Patient-Focused Label for the Future: Hot Air or Real Opportunities?
Speaker(s)
Setting the Scene
D.K.Theo Raynor, PhD, MPharm
University of Leeds, United Kingdom
Professor of Pharmacy Practice
ePI Principles
Elizabeth Scanlan, PhD, MSc
European Medicines Agency, Netherlands
ePI Product Owner
Panel discussion with Q&A, with the additional participation of:
Sabrina Conti, LLM
Medicines For Europe, Belgium
Policy and Regulatory Operations Manager
Panel discussion with Q&A, with the additional participation of:
Deborah Bebbington
Bayer Plc, United Kingdom
Head Global Labeling
Panel discussion with Q&A, with the additional participation of:
Cesar Hernandez Garcia
Spanish Agency For Medicines and Medical Devices, Spain
Head of Department, Department of Medicines for Human Use
Have an account?